Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Jun 15, 2025; 17(6): 105170
Published online Jun 15, 2025. doi: 10.4251/wjgo.v17.i6.105170
Published online Jun 15, 2025. doi: 10.4251/wjgo.v17.i6.105170
Figure 3 Kaplan–Meier curve estimate of duration of response, progression-free survival, and overall survival by mRECIST.
A: Duration of response; B: Progression-free survival; C: Overall survival. DOR: Duration of response; PFS: Progression-free survival; OS: Overall survival.
- Citation: Yang ZH, Liu SN, Chu FY, Yang C, Chen X. Efficacy and safety of donafenib plus transarterial chemoembolization and immunotherapy for hepatocellular carcinoma. World J Gastrointest Oncol 2025; 17(6): 105170
- URL: https://www.wjgnet.com/1948-5204/full/v17/i6/105170.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i6.105170